Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Invivyd To Contact Him Directly To Discuss
NEW YORK, Feb. 11, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (“Invivyd” or the “Company”) (NASDAQ: IVVD) and reminds investors of the April 3, 2023 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

If you have suffered losses exceeding $100,000 invest in Invivid stock or options between November 29, 2021 and December 14, 2021 and would like to discuss your legal rights, call Faruqi & Faruqi partners Josh Wilson
/cloudfront-us-east-1.images.arcpublishing.com/gray/G5M5MO5M3MMRSJPCYAMWAGHPJA.jpg)



